Managed Healthcare Executive
CONTINUE TO SITE >

OR WAIT 15 SECS

  • Formulary WatchFormulary Watch
  • Managed Healthcare Executive
  • Medical EconomicsMedical Economics
  • Physicians PracticePhysicians Practice
Managed Healthcare Executive
Managed Healthcare Executive
Spotlight
Autoimmune DiseasesCardiovascular DiseasesEyecareHow to Reduce Maternal, Infant Health Risks During COVID-19The Improving Patient Access Podcast
Business
View MoreBusiness StrategyConsumersDrug CostsDrug PipelineFormularyHealth ManagementHealth/Disease StrategyHospitals & ProvidersIndustry AnalysisPharmacyPolitics and PolicyPractice ManagementReimbursementTechnology
Clinical
View MoreAutoimmune DiseasesBiosimilarsDermatologyDiabetesEyecareHIVLeukemia and LymphomaMental HealthObstetrics-Gynecology & Women's HealthOncologyOpioidsPediatricsPlaque PsoriasisSolid TumorsUrology
News
Media
Expert Interviews
K-Cast
Medical World News
Podcasts
Population Health Perspectives
Conferences
Publications
MHE Publication
Supplements And Featured Publications
CME/CE
Resources
Sponsored
Surveys
Subscribe
eNewsletter
Print Subscription
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Informations

© 2021 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.

Spotlight
  • Autoimmune Diseases
  • Cardiovascular Diseases
  • Eyecare
  • How to Reduce Maternal, Infant Health Risks During COVID-19
  • The Improving Patient Access Podcast
BusinessSee All >
  • Business Strategy
  • Consumers
  • Drug Costs
  • Drug Pipeline
  • Formulary
  • Health Management
  • Health/Disease Strategy
  • Hospitals & Providers
  • Industry Analysis
  • Pharmacy
  • Politics and Policy
  • Practice Management
  • Reimbursement
  • Technology
ClinicalSee All >
  • Autoimmune Diseases
  • Biosimilars
  • Dermatology
  • Diabetes
  • Eyecare
  • HIV
  • Leukemia and Lymphoma
  • Mental Health
  • Obstetrics-Gynecology & Women's Health
  • Oncology
  • Opioids
  • Pediatrics
  • Plaque Psoriasis
  • Solid Tumors
  • Urology
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Informations
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.

Factors having greatest impact on performance in the next three years

October 1, 2009

State of the Industry survey results

"All of us in the industry are watching very carefully what's going on in Washington to determine the impact it's going to have not just on our organizations but on the industry in general," says Martin Hauser, president and CEO, SummaCare. "There's no doubt that change is going to come, but we're all going to have to remain flexible."

Administrative costs of insurance companies remain a political issue, but the irony is that plans already have a heavy administrative burden with existing regulations, according to Hauser. Like many organizations, SummaCare has a whole staff dedicated to compliance and regulatory review.

"There's a dollar amount attached to that, that somebody has to pay," he says.

As a result of the economic downturn, another influencing factor according to survey response, managed care overall has seen enrollment declines. The top 20 plans reported a 1% decline in the second quarter of 2009, while commercial PPO enrollment declined 5.3%. HMO/POS lives also declined 1.9%, according to Corporate Research Group.